Immunohistochemical expression of EGFR in colorectal adenocarcinoma and its correlation with the presence of lymph node metastases
作者： G. Kapogiannatos , D. Margaritis , R. Alevizou , I. Gogoulou , A. Nomicos
DOI: 10.1007/S13126-015-0242-1
关键词:
摘要: Aim-Background Colorectal adenocarcinoma is one of the most common malignancies in humans. Consequently, several studies attempt to determine prognosis and clarify a better potential therapeutic utility therapy-resistant tumours. Epidermal growth factor receptor (EGFR) implicated tumorigenesis has an important role cell proliferation, angiogenesis metastatic spread. It also target for many malignancies. This study aimed investigate expression EGFR colorectal cancer (CRC) its correlation with lymph node metastases.
springer.com
sci-hub.se 参考文章(19)
Constantinos P. Zambirinis, Paraskevas Stamopoulos, Sotirios-George Panoussopoulos, Konstantinos Bramis, George E. Theodoropoulos, John Bramis, Emmanouil Leandros, Joanna G. Papailiou, Eleni Karafoka, P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up. Anticancer Research. ,vol. 29, pp. 785- 791 ,(2009)
Yuanming Lu, Gao Jingyan, Song Baorong, Junjie Peng, Ye Xu, Sanjun Cai, Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer. Cancer Biomarkers. ,vol. 11, pp. 219- 226 ,(2012) , 10.3233/CBM-2012-00282
M. Fakih, R. Wong, Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer Current Oncology. ,vol. 17, pp. 3- 17 ,(2010) , 10.3747/CO.V17IS1.616
A.M. Kluftinger, B.W. Robinson, N.F. Quenville, R.J. Finley, N.L. Davis, Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer. Surgical Oncology-oxford. ,vol. 1, pp. 97- 105 ,(1992) , 10.1016/0960-7404(92)90062-P
Yanhong Deng, Brenda F Kurland, Jianping Wang, Jiong Bi, Wen Li, Sujata Rao, Ping Lan, Tongyu Lin, Edward Lin, None, High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor. American Journal of Clinical Oncology. ,vol. 32, pp. 245- 252 ,(2009) , 10.1097/COC.0B013E3181891326
Alan P. Venook, Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma Cancer. ,vol. 103, pp. 2435- 2446 ,(2005) , 10.1002/CNCR.21123
Barbara-Ann Adelstein, Timothy A. Dobbins, Carole A. Harris, Ian C. Marschner, Robyn L. Ward, A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer European Journal of Cancer. ,vol. 47, pp. 1343- 1354 ,(2011) , 10.1016/J.EJCA.2011.03.031
I Zlobec, T Vuong, S Hayashi, D Haegert, L Tornillo, L Terracciano, A Lugli, J Jass, A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy British Journal of Cancer. ,vol. 96, pp. 793- 800 ,(2007) , 10.1038/SJ.BJC.6603619
Frédéric Bibeau, Florence Boissière-Michot, Jean-Christophe Sabourin, Sophie Gourgou-Bourgade, Michèle Radal, Frédérique Penault-Llorca, Philippe Rochaix, Laurent Arnould, Marie-Pierre Bralet, David Azria, Marc Ychou, Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray. Virchows Archiv. ,vol. 449, pp. 281- 287 ,(2006) , 10.1007/S00428-006-0247-9
Claire L. Vale, Jayne F. Tierney, David Fisher, Richard A. Adams, Richard Kaplan, Timothy S. Maughan, Mahesh K.B. Parmar, Angela M. Meade, Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis. Cancer Treatment Reviews. ,vol. 38, pp. 618- 625 ,(2012) , 10.1016/J.CTRV.2011.11.002